BIOVISION Catalyzer will allow selected innovative life sciences Projects and seed stage Startups to connect with potential partners and pitch in front of a prestigious selection committee.
BIOVISION Investor is dedicated to life sciences startups seeking series A or series B funds within 18 months. The international selection committee gathers more than 15 partners from leading European Venture funds
Biovision 2017 Catalyzer and Investor participants will also be more than welcome to take part in and contribute during the Prospective sessions that will address the theme of From Global Health to One Health.
Should you wish to get further information on BIOVISION Catalyzer or Investor: